These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12186130)

  • 21. Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.
    Bardiès M; Bardet S; Faivre-Chauvet A; Peltier P; Douillard JY; Mahé M; Fiche M; Lisbona A; Giacalone F; Meyer P; Gautherot E; Rouvier E; Barbet J; Chatal JF
    J Nucl Med; 1996 Nov; 37(11):1853-9. PubMed ID: 8917192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEN 1 and 2: the role of diagnostic imaging.
    Gollini P; Cataldi A; Fava C
    Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
    J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of somatostatin analogs in the treatment of neuroendocrine tumours].
    Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L
    Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretargeting with the affinity enhancement system for radioimmunotherapy.
    Barbet J; Kraeber-Bodéré F; Vuillez JP; Gautherot E; Rouvier E; Chatal JF
    Cancer Biother Radiopharm; 1999 Jun; 14(3):153-66. PubMed ID: 10850300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A woman with a unilateral adrenal mass. The adrenal metastasis of a medullary carcinoma of the thyroid].
    Maroto P; Bellet M; Cruz F; Salazar R; Solá C
    Rev Clin Esp; 1995 Dec; 195(12):847-8. PubMed ID: 8599044
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
    J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Difficulties in diagnosis and localization of recurrent medullary thyroid carcinoma].
    Biterman A; Bloch B; Wolf T; Baron E; Lephel O; Cohen O
    Harefuah; 2002 Feb; 141(2):145-7, 223. PubMed ID: 11905084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and therapy of thyroid carcinoma].
    Hölting T; Herfarth C
    Dtsch Med Wochenschr; 1997 Sep; 122(36):1077-80. PubMed ID: 9333531
    [No Abstract]   [Full Text] [Related]  

  • 30. PET imaging of recurrent medullary thyroid cancer.
    Simon GH; Nitzsche EU; Laubenberger JJ; Einert A; Moser E
    Nuklearmedizin; 1996 Jun; 35(3):102-4. PubMed ID: 8710526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pre- and intraoperative localization of neuroendocrine tumors].
    Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
    Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AJR Teaching File: multiple symmetric abnormalities in a radionuclide bone scan.
    Nguyen BD; Ram PC
    AJR Am J Roentgenol; 2007 Sep; 189(3 Suppl):S32-4. PubMed ID: 17715075
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of PET in medullary thyroid carcinoma.
    Rufini V; Treglia G; Perotti G; Leccisotti L; Calcagni ML; Rubello D
    Minerva Endocrinol; 2008 Jun; 33(2):67-73. PubMed ID: 18388854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
    Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medullary thyroid carcinoma associated with hyperthyroidism: a case report and review of the literature.
    Habra MA; Hijazi R; Verstovsek G; Marcelli M
    Thyroid; 2004 May; 14(5):391-6. PubMed ID: 15186618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
    Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
    J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary thyroid carcinoma: a rare presentation as a hypervascular tumour.
    Li WY; Tomlinson MA; Bryson JM; Hopkins NF
    J Laryngol Otol; 2002 Aug; 116(8):647-9. PubMed ID: 12389699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of radiotherapy in the treatment of thyroid cancers].
    Schlumberger M
    Bull Cancer Radiother; 1994; 81(4):395-401. PubMed ID: 7702925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.